Author: The Bull Team

The Bull Team
The Bull Team

The Bull Team is a group of finance writers and journalists that provide commentary and insights on the Australian stock market and beyond.

feedback or questions?

Include your name, the article headline and your message.

EMAIL THE AUTHOR

FOLLOW ELSEWHERE

Recent and archived work by The Bull Team for The Bull:

Xero Shares (ASX: XRO) Up Big Thursday on Stellar Earnings Report

In a significant development for Australian stocks, Xero Limited (ASX: XRO), a prominent player in cloud-based accounting software, has witnessed its shares climb 8.74% following the disclosure of its FY24 earnings. The company’s impressive performance was highlighted by a 75% increase in adjusted EBITDA, reaching NZ$527 million, coupled with a noteworthy 22% rise in revenue…

IC Markets Integrates With TipRanks for Enhanced Research Tools

IC Markets, one of the world’s largest Forex CFD providers, has partnered with TipRanks, a premier provider of investment research tools. This partnership is aimed at enhancing investment and trading research capabilities for IC Markets’ clients, providing them access to TipRank’s sophisticated tools. Aligned with IC Markets’ 16-year commitment to making trading more accessible to…

BHP Teams Up with Kingsrose for Nordic Exploration

Kingrose Mining share price (ASX: KRM) added more than 20% in trading on Wednesday as news of a partnership with BHP emerges. BHP (ASX: BHP), one of the world’s leading multinational mining companies, and Australian junior miner Kingsrose Mining (ASX: KRM) have announced a significant alliance as the two companies publicized the signing of two…

lab lady looking into a microscope

Telix (ASX:TLX) Advances in Prostate Cancer Treatment

Telix Pharmaceuticals (ASX: TLX) has reached a significant milestone with the successful completion of the CUPID study, a Phase I trial focused on its investigational drug TLX592 for advanced prostate cancer patients.  Telix Pharmaceuticals share price has risen 71.90% in the last 6months and has added a further 2.53% in today’s session. The announcement has…

Bellevue Gold Shares (ASX: BGL) Have Added 60% In 12 Months, We Take A Look

Bellevue Gold shares (ASX:BGL) have taken holders on a upward curve over the past 12 months, adding 60.32% during a period where demand for gold, and the price of the commodity itself has gone on to reach record highs. With such an ascent for the metal, it is no surprise to see those involved in…

ASX 200 Closes on a 1.65% High as All Ords adds 1.61% – Highlighting Strong Performers

The ASX200  ended the day on a positive note, with the benchmark index closing at 7,881.3 points as the All Ords (XAO) closed out marginally above 8,150. The rise marked substantial gains of 1.65% and 1.61% respectively and reflects a broad uptrend in the market. Investors saw a mix of significant gains among top performers…

Vitura Health Limited (ASX: VIT)

Company Information   About Vitura Health Limited (ASX: VIT) Vitura Health Limited is a digital health company with a focus on various health-related businesses. It operates in three main segments. The Medical segment is involved in selling and distributing medical cannabis products. The Clinics segment runs medicinal cannabis clinics. The Consumer segment deals with non-medical…

Are Mergers and Acquisitions the Solution to Copper Supply Challenges?

In the face of a looming copper shortage crucial for the global energy transition, Mark Bristow, CEO of Barrick Gold (NYSE: GOLD), has openly expressed skepticism regarding the effectiveness of mergers and acquisitions (M&A) as a solution to the deficit. According to Bristow, the current consolidation wave, exemplified by BHP’s (ASX: BHP) potential $39 billion…

Tuesday Roundup – RBA Holds Steady As Local Markets Push On

Local markets had a good day with the ASX 200 index rising by 1.44%, closing at 7,793.30, the All Ordinaries (INDEXASX: XAO) followed suit, with a rise of 1.42% also, gaining 113.20 points. This uptick came on the heels of the Reserve Bank of Australia’s (RBA) decision to keep its benchmark lending rate steady at…

WBC

Westpac Rewards Shareholders Despite Earnings Dip

In a climate of financial headwinds, Westpac Banking Corporation (ASX: WBC) has revealed a downturn in its financial performance for the half-year period ending in March. The Australian banking titan registered a 16% decrease in net profit amid challenging market conditions. Consequently, Westpac’s earnings experienced an 8% contraction, coming in at $3.506 billion. Despite this…